AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16453953
Drug: 3 component
RxNorm normalized name: Syn023 component ctb012
DrugBank: Mazorelvimab (DB17767)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 component acellular pertussis vaccine (GlaxoSmithKline)
Trial: 16453953
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (Havrix) as a placebo
Trial: 9917047
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no steroid exposure)
Trial: 2197376
Drug: Propranolol-LA, 80-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol-LA, 80-mg tablets
Trial: 2197376
Drug: Atenolol, 50-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol, 50-mg tablets
Trial: 2197376
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no beta blocker therapy)
Trial: 12166539
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatments (MF and BDP)
Trial: 12166539
Drug: Active treatments
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatments (MF and BDP)
Trial: 7002568
Drug: Verapamil 80-160
RxNorm normalized name: verapamil hydrochloride 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 80-160 mg t.i.d. for 10 days
Trial: 30123523
Drug: Esmolol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol infusion
Trial: 14660159
Drug: Antiretroviral medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral medication adherence on drug use days
Trial: 14660159
Drug: Antiretroviral medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral medication adherence on matched abstinence days
Trial: 10719624
Drug: Spleen peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spleen peptide preparation (Polyerga) during chemotherapy (cisplatin/carboplatin, 5‐fluorouracil)
Trial: 29402522
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg/rosuvastatin 10 mg
Trial: 16682725
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (GCSF) added to prophylactic antibiotics
Trial: 8031229
Drug: Fluoxetine 40
RxNorm normalized name: fluoxetine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 40 mg/d
Trial: 12715267
Drug: Fluoxetine 60
RxNorm normalized name: fluoxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 60 mg/d
Trial: 2574627
Drug: Terfenadine 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 240 mg
Trial: 24955752
Drug: Lurasidone (40-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone (40-160 mg/d)
Trial: 10071998
Drug: Fentanyl (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (10 microg) added to 1.5% lidocaine (45 mg hyperbaric)
Trial: 10071998
Drug: 1.5% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5% lidocaine (45 mg hyperbaric) alone
Trial: 7706761
Drug: Single UV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single UV exposure with double the patient's minimal erythema dose
Trial: 7441622
Drug: Weekly reminders
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly reminders sent to two thirds of the doctors; remaining third did not receive reminders.
Trial: 27555197
Drug: Caudal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal dexmedetomidine (1 μg/kg) with caudal bupivacaine
Trial: 27555197
Drug: IV dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV dexmedetomidine (1 μg/kg)
Trial: 25001159
Drug: Ranibizumab intravitreal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab intravitreal administration
Trial: 22585883
Drug: Home blood
RxNorm normalized name: LifeSource Aneroid Home Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home blood pressure monitoring, weekly health coaching, and home titration of blood pressure medications (n = 129)
Trial: 22585883
Drug: Home blood
RxNorm normalized name: LifeSource Aneroid Home Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home blood pressure monitoring and health coaching but no home titration (n = 108)
Trial: 7004446
Drug: multivalent pneumococcal
RxNorm normalized name: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
DrugBank: Streptococcus pneumoniae type 8 capsular polysaccharide antigen (DB10326)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: multivalent pneumococcal polysaccharide vaccine
Trial: 21720264
Drug: Losartan-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan-based treatment
Trial: 17924869
Drug: Fenofibrate 80
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenofibrate 80 mg
Trial: 20662912
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate solution rinse for 60 seconds after exposure to hydrochloric acid (0.01 M, pH 2)
Trial: 20662912
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate solution rinse
Trial: 12467132
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of calcium + placebo
Trial: 22377512
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER (3-12 mg/day)
Trial: 10397416
Drug: Neuroleptic drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic drug therapy
Trial: 30281941
Drug: 4 mL
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mL mometasone furoate-soaked biodegradable nasal dressings (BNDs) for 1 week
Trial: 30281941
Drug: 4 mL
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mL mometasone furoate-soaked biodegradable nasal dressings (BNDs) for 2 weeks
Trial: 30281941
Drug: 8 mL
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mL mometasone furoate-soaked biodegradable nasal dressings (BNDs) for 1 week
Trial: 30281941
Drug: 8 mL
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mL mometasone furoate-soaked biodegradable nasal dressings (BNDs) for 2 weeks
Trial: 28710850
Drug: BAI 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAI 160 μg/day
Trial: 28710850
Drug: MDI 80
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI 80 μg/day
Trial: 28710850
Drug: MDI 160
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI 160 μg/day
Trial: 26034880
Drug: Dapivirine Vaginal
RxNorm normalized name: dapivirine
DrugBank: Dapivirine (DB08639)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapivirine Vaginal Ring (25 mg)
Trial: 26034880
Drug: Maraviroc Vaginal
RxNorm normalized name: Maraviroc
DrugBank: Maraviroc (DB04835)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maraviroc Vaginal Ring (100 mg)
Trial: 24204865
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment with educational handout
Trial: 24204865
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment without educational handout
Trial: 30085075
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment control group
Trial: 21806767
Drug: Aliskiren/Amlodipine 150/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren/Amlodipine 150/5 mg, then titrated to 300/10 mg
Trial: 24009042
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg)
Trial: 8558934
Drug: Historical control
RxNorm normalized name: typhus, historical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Historical control group (no G-CSF)
Trial: 6343309
Drug: Split course
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Split course therapy (3000 rad in 10 fractions over 2 weeks, a three‐week rest, 3000 rad in 10 fractions over 2 weeks)
Trial: 25567051
Drug: Avocado diet
RxNorm normalized name: Avocado
DrugBank: Avocado (DB10504)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avocado diet (AV) including one fresh Hass avocado (136 g) per day
Trial: 19561024
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow cells (BMCs) administered with each dose of cardioplegia antegradely into the coronaries
Trial: 11930742
Drug: O2 insufflation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: O2 insufflation for three times followed by complete absorption of CO2 after LC (Group C)
Trial: 9391248
Drug: Blood glucose
RxNorm normalized name: Blood Glucose Book
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood glucose concentration at 12 mmol/l
Trial: 8009346
Drug: Weekly physical
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly physical exercise before pregnancy
Trial: 31659541
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) at a dose of 4 J/cm2
Trial: 31659541
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) at a dose of 2 J/cm2
Trial: 27737649
Drug: Prolonged-release melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release melatonin (2 mg)
Trial: 21382896
Drug: Sildenafil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (20 mg three times daily) for 6 weeks
Trial: 16830289
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon alpha 2b 1.5 microg/kg s.c. weekly plus ribavirin adjusted for patient's weight
Trial: 3758142
Drug: 32.5 mg
RxNorm normalized name: phenol 32.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32.5 mg urapidil
Trial: 3758142
Drug: 65 mg
RxNorm normalized name: opium 65 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 65 mg urapidil
Trial: 3758142
Drug: 130 mg
RxNorm normalized name: pectin 130 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 130 mg urapidil
Trial: 31756281
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment for 3 months
Trial: 23257975
Drug: Pravastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10 mg/day)
Trial: 27037630
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of fluticasone propionate and salmeterol combinations administered by oral inhalation from three different batches.
Trial: 27037630
Drug: Replicated batch
RxNorm normalized name: covid-19, viral vector, non-replicating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Replicated batch administered in two treatment periods.
Trial: 20307680
Drug: Pump infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pump infusion system
Trial: 20307680
Drug: Gravity infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gravity infusion system
Trial: 17941096
Drug: Interpersonal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal therapy (IPT)
Trial: 393300
Drug: Guanethidine and
RxNorm normalized name: guanethidine and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanethidine and adrenaline formulation (3.0% and 0.5%)
Trial: 393300
Drug: Guanethidine and
RxNorm normalized name: guanethidine and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanethidine and adrenaline formulation (1.0% and 0.2%)
Trial: 19302641
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg.kg(‐1)
Trial: 23574713
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid vaginal gel (Hyalofemme)
Trial: 23574713
Drug: Estriol cream
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estriol cream (Ovestin)
Trial: 18312937
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no infusion)
Trial: 15967546
Drug: Nicotine patches
RxNorm normalized name: NICOTINE 7 mg in 1 g TRANSDERMAL PATCH [Sielkin QUIT SMOKING NICOTINE PATCHES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patches (15 mg/16 hr)
Trial: 14872504
Drug: Etoricoxib 120
RxNorm normalized name: etoricoxib 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 120 mg once daily
Trial: 12907325
Drug: Nonselective NSAIDs
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonselective NSAIDs (ibuprofen, naproxen, or diclofenac)
Trial: 10234793
Drug: F-ESWL (fragments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F-ESWL (fragments <= 4 mm, concomitant oral chemolitholysis)
Trial: 2062518
Drug: 100% oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100% oxygen and 20 mg diazepam
Trial: 30700328
Drug: pTVG-HP DNA
RxNorm normalized name: Toxoplasma gondii DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pTVG-HP DNA vaccine and pembrolizumab
Trial: 29532734
Drug: sirukumab 50
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirukumab 50 mg every 4 weeks (q4w)
Trial: 29532734
Drug: sirukumab 100
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirukumab 100 mg every 2 weeks (q2w)
Trial: 18694046
Drug: Self administered
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self administered questionnaire on computer
Trial: 12569085
Drug: C +
RxNorm normalized name: Probiotic + Colostrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C + AA (hydrocortisone sodium succinate infusion at 80 microg. kg(‐1). h(‐1))
Trial: 12569085
Drug: AA (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AA (intravenous saline)
Trial: 11126816
Drug: Tropisetron (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron (2 mg intravenously at induction)
Trial: 9175044
Drug: rHuEpo therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEpo therapy (50 IU/kg intravenously or 35 IU/kg subcutaneously for the first 6 months, then 20 IU/kg)
Trial: 9175044
Drug: rHuEpo therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEpo therapy
Trial: 3907677
Drug: Oxyfedrine 24
RxNorm normalized name: oxyfedrine 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxyfedrine 24 mg four times daily
Trial: 29193677
Drug: Gallic Acid
RxNorm normalized name: gallic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallic Acid (GA) 15 mg p-1 d-1 for 7 days
Trial: 31623572
Drug: Posterior QLB
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posterior QLB (QLB‐2) using 20 ml 0.25% bupivacaine
Trial: 30160789
Drug: Intravenous arsenic
RxNorm normalized name: arsenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous arsenic trioxide (ATO)
Trial: 30160789
Drug: Oral Realgar-Indigo
RxNorm normalized name: indigo
DrugBank: Indigo (DB16862)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Realgar-Indigo naturalis formula (RIF)
Trial: 27434598
Drug: Cognitive-Behavioral Conjoint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Conjoint Therapy for PTSD (CBCT for PTSD)
Trial: 25112087
Drug: Calcium tablets
RxNorm normalized name: Leucovorin Calcium Tablets
DrugBank: Calcium sulfate (DB15533)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium tablets (caltrate, 600 mg per day)
Trial: 19436693
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 microg daily
Trial: 17226908
Drug: Continuous ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous ciprofloxacin treatment (200 mg intravenous injection for 30 min before ERCP and continued until 48 hours after ERCP)
Trial: 12086757
Drug: rFGF-2 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rFGF-2 (30 microg/kg) on day 1 and placebo on day 30 (single-dose, n=66)
Trial: 8594524
Drug: Bausch &
RxNorm normalized name: Sodium Chloride Nasal Spray [BAUSCH & LOMB]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bausch & Lomb ReNu (multipurpose contact lens care solution)
Trial: 21676221
Drug: Lisinopril 5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 5‐10 mg daily for 7 days
Trial: 19366273
Drug: Sublingual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual administration of 25 mg ketamine lozenge
Trial: 16427197
Drug: High plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High plasma morphine concentrations (173+/‐11 ng/ml)
Trial: 10332529
Drug: Computer-based program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-based program for identifying drug-related problems
Trial: 7418714
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg methotrexate bolus intravenous injection
Trial: 7418714
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg methotrexate bolus intravenous injection
Trial: 24512733
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin C 320 mg/kg
Trial: 24512733
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin C 480 mg/kg
Trial: 3443154
Drug: Fenoterol 5
RxNorm normalized name: fenoterol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol 5 mg
Trial: 31454351
Drug: Standard RUTF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard RUTF dose throughout treatment
Trial: 31454351
Drug: Reduced RUTF
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced RUTF dose after two weeks
Trial: 31454351
Drug: Reduced RUTF
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced RUTF dose after two weeks (children under 12 months)
Trial: 27472271
Drug: Complementary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary and alternative medicine (CAM)
Trial: 17109866
Drug: Fenofibrate (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (160 mg/day)
Trial: 8027926
Drug: Buccoadhesive tablet
RxNorm normalized name: testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccoadhesive tablet
Trial: 8027926
Drug: Sublingual capsule
RxNorm normalized name: Sublingual Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual capsule
Trial: 2644962
Drug: Amethocaine preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amethocaine preparation (0.5 g applied for 30 min)
Trial: 2644962
Drug: Eutectic Mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eutectic Mixture of Local Anaesthetics (EMLA) (2.5 g applied for 60 min under an occlusive dressing)
Trial: 2644962
Drug: Amethocaine preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amethocaine preparation vs EMLA
Trial: 53598
Drug: Twice-weekly isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly isoniazid 15 mg/kg plus rifampicin 900 mg (HR2 regimen)
Trial: 53598
Drug: Twice-weekly isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly isoniazid 15 mg/kg plus rifampicin 600 mg (LR2 regimen)
Trial: 53598
Drug: Once-weekly isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly isoniazid 15 mg/kg plus rifampicin 900 mg (HR1 regimen)
Trial: 53598
Drug: Once-weekly isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly isoniazid 15 mg/kg plus rifampicin 600 mg (LR1 regimen)
Trial: 53598
Drug: Rifampicin 25
RxNorm normalized name: Rifampicine
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin 25 mg supplement
Trial: 31276986
Drug: Enhanced profile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced profile with graphical representation of prescriptions and identified risky prescribing patterns
Trial: 26117150
Drug: Self-administered LAIV
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered LAIV (SA)